What is the long-term trend for Thermo Fisher Scientific's analytical instruments — acquisitions?

Over 4 years (2021 to 2025), Thermo Fisher Scientific's analytical instruments — acquisitions has grown at a -100.0% compound annual growth rate (CAGR), from $56M to $0.

What does analytical instruments — acquisitions mean?

Captures the capital deployed to purchase other companies or business units specifically to bolster the Analytical Instruments product portfolio. This metric tracks inorganic growth investments aimed at expanding technological capabilities or market share.

Thermo Fisher Scientific (TMO) Analytical Instruments — Acquisitions

Screener

Other segment segments

Life Sciences Solutions

$2.1B-8.7%

Laboratory Products and Biopharma Services

$15M—

Specialty Diagnostics

$0—

Similar metrics at other companies

MSCIAnalytics — Acquisitions

$0—

HDOther — Acquisitions

$109M+419%

HPQPrinting — Acquisitions

$0-100%

UNHUnitedHealthcare — Acquisitions

$0—

CSCOAmericas — Acquisitions

$18M-18.2%

LZBRetail — Acquisitions

$14.41M+275%

Other financials

Income statement

See full

Revenue$12.0B—

Operating income$2.1B—

Net income$1.7B+7.4%

EPS (diluted)$4.68+9.3%

Balance sheet

See full

Cash & equivalents$4.1B-11.7%

Total debt$39.2B+4.6%

Total equity$52.7B+4.3%

Total assets$113.17B+11.8%

Cash flow

See full

Operating cash flow$2.1B+51.9%

CapEx-$1.2B-509%

Free cash flow$923.0M-16.5%

Valuation

See full

Market cap$213.65B+26.0%

Enterprise value$248.77B+22.9%

P/E30.7×+4.9×

P/S4.8×-0.9×

Profitability

See full

Gross margin58.3%—

Operating margin17.2%+0.8pp

Net margin15.2%+1.0pp

FCF margin15.7%-2.1pp

Returns & leverage

See full

Return on equity13.5%+0.1pp

Debt / equity0.7×0.0×

Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The source filing: Thermo Fisher Scientific’s 10-K, filed February 26, 2026.

Filed: Feb 26, 2026, 12:11 PM EST
Fiscal year: FY2025
Accession: 0000097745-26-000018

(In millions)	Life Sciences Solutions	Analytical Instruments	Specialty Diagnostics	Laboratory Products and Biopharma Services	Total
Balance at December 31, 2023	$10,151	$5,051	$4,923	$23,895	$44,020
Acquisitions	2,302	—	—	—	2,302
Currency translation	(117)	(92)	(139)	(122)	(470)
Balance at December 31, 2024	12,336	4,959	4,784	23,773	45,853
Acquisitions	2,101	—	—	15	2,117
Currency translation	473	184	292	444	1,393
Balance at December 31, 2025	$14,910	$5,143	$5,076	$24,232	$49,362

Item 8. Financial Statements and Supplementary Data

FAQ

What is Thermo Fisher Scientific's analytical instruments — acquisitions?: Thermo Fisher Scientific (TMO) reported analytical instruments — acquisitions of $0 in Q4 2025.
What is the long-term trend for Thermo Fisher Scientific's analytical instruments — acquisitions?: Over 4 years (2021 to 2025), Thermo Fisher Scientific's analytical instruments — acquisitions has grown at a -100.0% compound annual growth rate (CAGR), from $56M to $0.
What does analytical instruments — acquisitions mean?: Captures the capital deployed to purchase other companies or business units specifically to bolster the Analytical Instruments product portfolio. This metric tracks inorganic growth investments aimed at expanding technological capabilities or market share.